DRH1 – a novel blood-based HPV tumour marker

BACKGROUND: To date, no studies have successfully shown that a highly specific, blood-based tumour marker to detect clinically relevant HPV-induced disease could be used for screening, monitoring therapy response or early detection of recurrence. This study aims to assess the clinical performance of...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:EBioMedicine
Päätekijät: Weiland, Thomas, Eckert, Alexander, Tomazic, Peter Valentin, Wolf, Axel, Pondorfer, Prisca, Vasicek, Sarah, Graupp, Matthias, Holzmeister, Clemens, Moser, Ulrich, Andrianakis, Alexandros, Kangler, Georg, Kiss, Peter, Brcic, Luka, Kappler, Matthias, Wickenhauser, Claudia, Haak, Anja, Krüger, Maximilian, Al-Nawas, Bilal, Blatt, Sebastian, Brockmeyer, Norbert, Skaletz-Rorowski, Adriane, Potthoff, Anja, French, Lars E., Charnowski, Sara, Reinholz, Markus, Kaufmann, Andreas M., Thies, Sarah, Lambrecht, Hans-Georg, Seliger, Barbara, Wild, Dominik C., Thurnher, Dietmar
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier 2020
Aiheet:
Research paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7300133/
https://ncbi.nlm.nih.gov/pubmed/32535546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2020.102804
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia